Director position in Quantitative Clinical Pharmacology at Novo Nordisk (Denmark)
Dear all,
we are looking to employ a new Director of Quantitative Clinical Pharmacology
to lead our team of highly dedicated experts within quantitative clinical
pharmacology and model-based analyses.
As Director of Quantitative Clinical Pharmacology (QCP), you are responsible
for management of the department and the QCP deliveries, including development
of staff and department. You are responsible for the QCP deliveries in
accordance with the project milestones. You will supervise all modelling
activities in the department and mentor scientists and align with department
strategy.
You hold a relevant university degree, e.g. statistics, engineering, pharmacy
or other, preferably complemented by a PhD and are experienced with people
management. You have expert knowledge within modelling and regulatory
interactions, and have a minimum of 6 years' experience from the pharmaceutical
industry. You must have in depth understanding of
pharmacokinetics/pharmacodynamics, statistical methodology, and data
interpretation as well as hands-on experience performing model-based analyses.
For the full job description and qualifications for this position, visit
http://www.novonordisk.com/careers/job_section/jp.asp?jobid=23894BR&joblng=uk&jobcnt=Denmark&type=1a
Please refer to the website for contact information and to apply for the
position.
With best regards,
Daniël Jonker
____________________________________
Daniël Jonker
Senior Modelling Scientist
Quantitative Clinical Pharmacology
Novo Nordisk A/S
Vandtårnsvej 108-110
DK-2860 Søborg
Denmark
[email protected]
http://www.facebook.com/novonordisk |
http://www.twitter.com/novonordisk |
http://www.linkedin.com/company/novo-nordisk |
http://www.Youtube.com/novonordisk |
http://www.pinterest.com/novonordisk
This e-mail (including any attachments) is intended for the addressee(s) stated
above only and may contain confidential information protected by law. You are
hereby notified that any unauthorized reading, disclosure, copying or
distribution of this e-mail or use of information contained herein is strictly
prohibited and may violate rights to proprietary information. If you are not an
intended recipient, please return this e-mail to the sender and delete it
immediately hereafter. Thank you.